Novo Nordisk's oral drug Rybelsus, a version of semaglutide, has shown promising results in reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease and/or chronic kidney disease in a late-stage study.
A longitudinal study of transgender youth found 97% continued gender-affirming medical care years after starting, with high satisfaction and low regret reported for both puberty blockers and hormones.
A recent study revealed associations between cardiometabolic index (CMI), insulin resistance (IR), prediabetes (preDM), and type 2 diabetes mellitus (T2D) in U.S. adults, showing elevated CMI is linked to a higher likelihood of developing IR, preDM, and T2D, with a plateau effect suggesting maintaining CMI at certain levels is beneficial.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Older adults with higher BMI and better diet quality experienced a slower decline in depressive symptoms over a 4-year period, suggesting a potential protective effect.
Recent study in BMJ Open Gastroenterology shows significant differences in gallstone disease incidence between men and women in Chile, with unique risk factors for each gender.